Dr. George P. Bayliss, MD

Dr. Bayliss practices at Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island.

Dr. Bayliss' NPI, 1982892824, was assigned on October 4, 2007. Dr. Bayliss graduated from The Warren Alpert Medical School of Brown University in 2003. Dr. Bayliss holds Rhode Island license MD12642.

Dr. Bayliss' primary practice is Rhode Island Hospital/Hasbro Children's, at 593 Eddy St, Providence, RI 02903 in Providence County. The practice phone is (401) 444-6966.

Dr. Bayliss' primary practice is Rhode Island Hospital/Hasbro Children's in Providence, Rhode Island. Dr. Bayliss is also affiliated with The Miriam Hospital. The medical group on file is Brown Medicine. Dmand AI also links Dr. Bayliss to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bayliss practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Bayliss' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Bayliss is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bayliss' licenses on file in 2 states: Rhode Island and Massachusetts.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, gout and kidney disease among the conditions Dr. Bayliss treats.

CMS data shows 552 Medicare services from Dr. Bayliss across 4 procedure codes in 2024, for 252 Medicare patients. Medicare paid $47,187 for them.

CMS counts 252 Medicare patients who saw Dr. Bayliss in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 3.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bayliss' median patient age at 63, with 45% women.

In 2024, Dr. Bayliss wrote 2,161 Medicare Part D claims for 238 patients. 85% of them were for generic drugs. CMS names the drug for 1,826 of them, across 45 drugs with 11 or more claims each, at $229,960 in total drug cost.

Dr. Bayliss accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bayliss as offering telehealth.

Dmand AI links 83 papers to Dr. Bayliss, published from 2009 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Kidney, Phosphorylation and Signal Transduction. Dr. Bayliss has published most often in Am J Physiol Renal Physiol. Dr. Bayliss' most frequent co-authors are Larry A. Weinrauch, MD, John Anthony D'Elia, MD and Reginald Y. Gohh, MD.

CMS Open Payments shows 1 general payment to Dr. Bayliss from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $0.

Dmand AI lists 1 award for Dr. Bayliss, most recently CMS Stage 1 EHR in 2013.

Dr. Bayliss graduated from The Warren Alpert Medical School of Brown University in 2003. Dr. Bayliss is a member of ACP.

Dr. Bayliss is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.